Research / QXL / Fundamental state Inspectable configuration
State dimensions Filing 0001493152-23-041065 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
67.08% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.02% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation 69th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1.76% · OPTIONAL · VALID
Revenue growth 67th Own-history percentile · N=12
Evidence method Yoy · gp.fundamentals.revenue
-31.01% · CORE · VALID
Operating margin 50th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.operating_margin
-10.51% · CORE · VALID
R&D intensity 38th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.45% · OPTIONAL · VALID
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.27% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Jun 30, 2021 0/6 normalized Level 3 Sep 30, 2021 4/6 normalized Level 3 Dec 31, 2021 4/5 normalized Level 3 Mar 31, 2022 4/6 normalized Level 3 Jun 30, 2022 4/6 normalized Level 3 Sep 30, 2022 4/7 normalized Level 3 Sep 30, 2022 4/7 normalized Amended as filed Dec 31, 2022 4/7 normalized Level 3 Mar 31, 2023 4/6 normalized Level 3 Jun 30, 2023 4/7 normalized Level 3 Sep 30, 2023 4/7 normalized Level 3 Dec 31, 2023 4/7 normalized Level 3 Mar 31, 2024 4/6 normalized Level 3 Jun 30, 2024 4/6 normalized Level 3 Sep 30, 2024 5/6 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 5/5 normalized Level 3 Jun 30, 2025 5/5 normalized Level 3 Sep 30, 2025 6/6 normalized Level 3 Jun 30, 2026 5/5 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 40.54%
Current 67.08%
Delta 26.55% Capex Intensity Decreased
Previous 0.03%
Current 0.02%
Delta -0.01% Cash Generation Decreased
Previous 3.69%
Current -1.76%
Delta -5.45% Growth Decreased
Previous 1357600.00%
Current -31.01%
Delta -1357631.01% Profitability Decreased
Previous 0.92%
Current -10.51%
Delta -11.43% R And D Intensity Increased
Previous 2.64%
Current 4.45%
Delta 1.81% Sbc Intensity Increased
Previous 0.17%
Current 0.27%
Delta 0.11% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.